We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Livanova | LSE:LIVN | London | Ordinary Share | GB00BYMT0J19 | ORD GBP1.00 (DI) |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 50.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Apr 2019 to Apr 2024
TIDMLIVN
03 January 2017
TOTAL VOTING RIGHTS AND SHARE CAPITAL
In accordance with Disclosure and Transparency Rule 5.6, LivaNova PLC (the "Company") hereby notifies the market that as of 30 December 2016, the Company's capital consists of 48,156,690 ordinary shares of GBP1.00 each. The Company does not hold any shares in treasury.
Therefore, the total number of voting rights in the Company is 48,156,690. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interests in, or a change to their interest in, the Company under the Disclosure and Transparency Rules.
About LivaNova
LivaNova PLC is a global medical technology company formed by the merger of Sorin S.p.A, a leader in the treatment of cardiovascular diseases, and Cyberonics Inc., a medical device company with core expertise in neuromodulation. LivaNova transforms medical innovation into meaningful solutions for the benefit of patients, healthcare professionals, and healthcare systems. The Company employs approximately 4,600 employees worldwide and is headquartered in London, U.K. With a presence in more than 100 countries, LivaNova operates as three business units: Cardiac Surgery, Cardiac Rhythm Management, and Neuromodulation, with operating headquarters in Clamart (France), Mirandola (Italy) and Houston (U.S.), respectively.
LivaNova is listed on NASDAQ and listed on the Official List of the UK's Financial Conduct Authority and traded on London Stock Exchange (LSE) under the ticker symbol "LIVN".
For more information, please visit www.livanova.com, or contact:
Investor Relations and Media
Karen KingVice President, Investor Relations & Corporate CommunicationsPhone: +1 (281) 228-7262Fax: +1 (281) 218-9332e-mail: corporate.communications@livanova.com
View source version on businesswire.com: http://www.businesswire.com/news/home/20170102005169/en/
This information is provided by Business Wire
(END) Dow Jones Newswires
January 03, 2017 02:00 ET (07:00 GMT)
1 Year Livanova Chart |
1 Month Livanova Chart |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
